← Eichor
Condition: Bipolar Ii Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Bipolar Ii Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Type D Personality and Life Satisfaction in Bipolar Disorder Type 2 and Major Depressive Disorder
Phase N/A · 1 location(s) · Elazığ Mental Health and Diseases Hospital · NCT07679204A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipola
Phase 3 · 28 location(s) · Xenon Pharmaceuticals Inc. · NCT07172516Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · 68 location(s) · Intra-Cellular Therapies, Inc. · NCT06372964FOCUS Bipolar: Families Opening Conversations for Understanding Signs
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT07622927Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Type
Phase 3 · 1 location(s) · University of Sao Paulo · NCT07412132SYNCED - SYNChronized Eating in Bipolar Depression Study
NA · 1 location(s) · University of Ottawa · NCT06560957Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
Phase 1 · 1 location(s) · University Health Network, Toronto · NCT06506019Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression
NA · 1 location(s) · Andrew Krystal · NCT07127913Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · 49 location(s) · AbbVie · NCT07220460ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · 27 location(s) · Alto Neuroscience · NCT06656416LHC-CIDI-5 in Hong Kong
Phase N/A · 1 location(s) · The University of Hong Kong · NCT06804525Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
NA · 4 location(s) · University of California, Los Angeles · NCT06920940The COSMYC Trial (COmbined Suppression of MYC)
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06922318Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT05064319Biocollection on Peripheral Inflammation
Phase N/A · 1 location(s) · Nantes University Hospital · NCT05934474Exercise and Olanzapine-samidorphan
Phase 4 · 1 location(s) · New York State Psychiatric Institute · NCT06740890A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
Phase 3 · 1 location(s) · Korea Otsuka Pharmaceutical Co., Ltd. · NCT03423680Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · 33 location(s) · AbbVie · NCT06696755Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Phase 4 · 1 location(s) · University Hospital Bispebjerg and Frederiksberg · NCT06184581The Bipolar Lithium Imaging Scan Study.
Phase N/A · 1 location(s) · Leiden University Medical Center · NCT06134349Children's Bipolar Network Treatment Trial I
Phase N/A · 4 location(s) · University of California, Los Angeles · NCT05427123Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06706232Decoding Emotional Dynamics in Bipolar Disorder
NA · 1 location(s) · Laureate Institute for Brain Research, Inc. · NCT07221864
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.